News | SPECT-CT | March 11, 2022

NeuroLogica’s OmniTom Elite has received 510(k) clearance for the addition of Photon Counting Detector (PCD) technology

NeuroLogica’s OmniTom Elite has received 510(k) clearance for the addition of Photon Counting Detector (PCD) technology

March 11, 2022 — The world of medical imaging is no longer just black and white. NeuroLogica Corp., a subsidiary of Samsung Electronics Co. Ltd., announced today its state-of-the-art OmniTom Elite has received 510(k) clearance for the addition of Photon Counting Detector (PCD) technology. NeuroLogica delivers the first FDA 510(k) cleared, single-source photon counting computed tomography (CT) scanner with single detector on a mobile system. OmniTom Elite with PCD can generate spectral CT images at multiple energy levels.

Photon counting is a next-generation CT technology that sorts the different energies of X-rays after they have passed through the scan field. A single X-ray source paired with PCD generates multiple sets of CT data acquired at the same time with configurable energy thresholds without any cross talk between images. PCD provides the ability to capture CT data in multiple energy bands leading to potentially more accurate visualization and segmentation of bone, blood clots, plaque, hemorrhage, and intracranial tumors. There is also potential with PCD to lower the dose requirements, and fundamentally change the use of injected contrast.

“NeuroLogica is driven by innovation. Since the advent of the world’s first multi-slice mobile CT in 2004, we have always known that point-of-care imaging can improve patient outcomes and increase the likelihood of a better quality of life after a traumatic event,” said David Webster, Chief Operating Officer of NeuroLogica. “With the introduction of PCD technology to the OmniTom Elite platform, we look to expand the diagnostic possibilities of CT at the patient’s bedside.”

The OmniTom Elite has the ability to provide versatile, real-time mobile imaging to administer point-of-care CT to critical patients without the need to transport them to a separate imaging department. The mobile unit will decrease the time it takes to diagnose and initiate treatment for these critical patients.

“Availability of photon-counting detector technology on a mobile head CT platform is a significant advance in the development of CT,” said Rajiv Gupta, PhD, MD, Neuroradiology Division Chief of Massachusetts General Hospital and Associate Professor at Harvard Medical School. “This advance heralds a new era of CT applications in stroke, trauma, ICU and intra-op settings.” MGH is collaborating with NeuroLogica and will pilot test the OmniTom Elite with PCD to monitor post-trauma and post-surgical patients.

Upgrading capabilities were top of mind when designing OmniTom Elite mobile CT scanners. In the near term, all current OmniTom users will have the opportunity to upgrade their scanners with this technology. Meanwhile, a limited number of premier research partners will aid in developing the full potential of OmniTom Elite with PCD.

NeuroLogica’s OmniTom Elite, and the entire mobile CT product line are manufactured in Danvers, MA, USA. 

For more information: www.neurologica.com

Related Photon-counting CT Content:

Mayo Clinic Begins Use of Third-Generation Photon-counting CT Clinical Research Detector

VIDEO: New Advances in CT Imaging Technology — Interview with Cynthia McCollough, Ph.D.

VIDEO: Photon Counting Detectors Will be the Next Major Advance in Computed Tomography — Interview with Todd Villines, M.D.

Key Trends in Cardiac CT at SCCT 2020

GE Healthcare Pioneers Photon Counting CT with Prismatic Sensors Acquisition

Top Trend Takeaways in Radiology From RSNA 2020

NeuroLogica Joins Forces with Massachusetts General Hospital to Pilot Photon Counting CT at the Patient’s Point-Of-Care Using OmniTom Elite CT

VIDEO: Advances in Cardiac CT Imaging — Interview with David Bluemke, M.D.


Related Content

News | Computed Tomography (CT)

November 28, 2023 — Smoking marijuana in combination with cigarettes may lead to increased damage of the lung’s air sacs ...

Time November 28, 2023
arrow
News | RSNA

November 27, 2023 — Black patients underwent medical imaging for cognitive impairment years later than white and ...

Time November 27, 2023
arrow
News | Quality Assurance (QA)

November 25, 2023 — Mirion announced that it will debut the new Instadose VUE personal dosimeter, from its Dosimetry ...

Time November 25, 2023
arrow
News | Radiology Imaging

November 23, 2023 — Fujifilm Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging ...

Time November 23, 2023
arrow
News | Lung Imaging

November 22, 2023 — Using a routine chest X-ray image, an artificial intelligence (AI) tool can identify non-smokers who ...

Time November 22, 2023
arrow
News | Artificial Intelligence

November 21, 2023 — Heuron, a medical AI (artificial intelligence) imaging software solution company, under the ...

Time November 21, 2023
arrow
News | Information Technology

November 21, 2023 — GE HealthCare has received U.S. FDA 510(k) Clearance for the new version of Digital Expert Access ...

Time November 21, 2023
arrow
News | Coronavirus (COVID-19)

November 20, 2023 — Using an image-guided minimally invasive procedure, researchers may be able to restore the sense of ...

Time November 20, 2023
arrow
News | Computed Tomography (CT)

November 17, 2023 — With the SOMATOM Pro.Pulse1, Siemens Healthineers presents a new Dual Source computed tomography (CT ...

Time November 17, 2023
arrow
News | Artificial Intelligence

November 15, 2023 — The 2023 Radiological Society of North America (RSNA) Alexander R. Margulis Award for Scientific ...

Time November 15, 2023
arrow
Subscribe Now